Clinical trial
Use of Antibiotics-cement Coated Plate in the Treatment of Gustilo-Anderson Type III Long Bone Fractures in Low- and Middle-income Countries vs External Fixation: A Multi-centre Randomized Control Trial
NCT06193330 is registered in ClinicalTrials.gov with Oluwasegun Aremu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Use of Antibiotics-cement Coated Plate in the Treatment of Gustilo-Anderson Type III Long Bone Fractures in Low- and Middle-income Countries vs External Fixation: A Multi-centre Randomized Control Trial
- Lead sponsor
- Oluwasegun Aremu
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 1, 2024
- Completion date
- December 31, 2026
- Enrollment
- 178 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
fracture related infection